These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27069542)

  • 1. Prognostic significance of aromatase and estrogen receptor beta expression in EGFR wild-type lung adenocarcinoma.
    Tanaka K; Shimizu K; Kakegawa S; Ohtaki Y; Nagashima T; Kaira K; Horiguchi J; Oyama T; Takeyoshi I
    Am J Transl Res; 2016; 8(1):81-97. PubMed ID: 27069542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic expression of estrogen receptor β may predict poor outcome of EGFR-TKI therapy in metastatic lung adenocarcinoma.
    Ding X; Li L; Tang C; Meng C; Xu W; Wei X; Guo Z; Zhang T; Fu Y; Zhang L; Wang X; Lin L; Liang J
    Oncol Lett; 2018 Aug; 16(2):2382-2390. PubMed ID: 30013628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.
    Stabile LP; Dacic S; Land SR; Lenzner DE; Dhir R; Acquafondata M; Landreneau RJ; Grandis JR; Siegfried JM
    Clin Cancer Res; 2011 Jan; 17(1):154-64. PubMed ID: 21062926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
    Nose N; Sugio K; Oyama T; Nozoe T; Uramoto H; Iwata T; Onitsuka T; Yasumoto K
    J Clin Oncol; 2009 Jan; 27(3):411-7. PubMed ID: 19064969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomas.
    Toh CK; Ahmad B; Soong R; Chuah KL; Tan SH; Hee SW; Leong SS; Tan EH; Lim WT
    J Thorac Oncol; 2010 Jan; 5(1):17-22. PubMed ID: 19875972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations.
    Kohno M; Okamoto T; Suda K; Shimokawa M; Kitahara H; Shimamatsu S; Konishi H; Yoshida T; Takenoyama M; Yano T; Maehara Y
    Clin Cancer Res; 2014 Jul; 20(13):3613-22. PubMed ID: 24803578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic values of estrogen receptor alpha and beta in patients with gastroesophageal cancer: A meta-analysis.
    Zhang D; Ku J; Yi Y; Zhang J; Liu R; Tang N
    Medicine (Baltimore); 2019 Nov; 98(46):e17954. PubMed ID: 31725654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
    Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
    J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery.
    Isaka T; Nakayama H; Ito H; Yokose T; Yamada K; Masuda M
    BMC Cancer; 2018 Oct; 18(1):959. PubMed ID: 30290774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic expression of G protein-coupled estrogen receptor 1 correlates with poor postoperative prognosis in non-small cell lung cancer.
    Li ZH; Liu C; Liu QH; Wang J; Wang Y; Wang YF; Deng SJ; Li DB
    J Thorac Dis; 2022 May; 14(5):1466-1477. PubMed ID: 35693608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue.
    Fasco MJ; Hurteau GJ; Spivack SD
    Mol Cell Endocrinol; 2002 Feb; 188(1-2):125-40. PubMed ID: 11911952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG; Fischer BM; Pappot H
    Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma.
    Takamochi K; Oh S; Matsunaga T; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1768-1774.e1. PubMed ID: 28826599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
    Mah V; Marquez D; Alavi M; Maresh EL; Zhang L; Yoon N; Horvath S; Bagryanova L; Fishbein MC; Chia D; Pietras R; Goodglick L
    Lung Cancer; 2011 Nov; 74(2):318-25. PubMed ID: 21511357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.
    Skjefstad K; Grindstad T; Khanehkenari MR; Richardsen E; Donnem T; Kilvaer T; Andersen S; Bremnes RM; Busund LT; Al-Saad S
    Steroids; 2016 Sep; 113():5-13. PubMed ID: 27234503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Ann Surg Oncol; 2017 Mar; 24(3):770-777. PubMed ID: 27696172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.
    Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):556-62. PubMed ID: 24760387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.